Insurance coverage may vary
We offer 3mg, 7mg, and 14mg Rybelsus tablets, all from certified manufacturing sources
Finally, more than 40% of patients initially at very high CKD risk were at high, moderate, or low/no CKD risk at 12 months ( Figure 4D )
Additionally, on April 30, 2026, one of Novo Nordisks competitors completed phase three of a clinical trial of a drug that they hope will help people lose weight and reduce liver fat. The clinical trial involved people who have obesity or are overweight and have also been diagnosed with a specific type of liver disease
Biguanides: Metformin as the Gold Standard First-Line Treatment Metformin is seen as the top choice for treating type 2 diabetes
Zhang C, Li Z, Wang J, et al